AstraZeneca Pharma India Limited (BOM:506820)
India · Delayed Price · Currency is INR 8,984.05
+188.65 (2.14%)
At close: May 26, 2026
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 216.38 billion as of May 27, 2026. Its market cap has increased by 5.86% in one year.
Market Cap
216.38B
Enterprise Value
213.00B
Revenue
23.04B
Ranking
n/a
PE Ratio
115.39
Stock Price
8,984.05
Market Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 216.38B, an increase of 14,822.93%. That is a compound annual growth rate of 22.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 216.38B | -3.94% |
| Dec 31, 2025 | 225.25B | 23.26% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 586.53B |
| GlaxoSmithKline Pharmaceuticals | 386.78B |
| J. B. Chemicals & Pharmaceuticals | 351.43B |
| Granules India | 187.53B |
| Jubilant Pharmova | 156.06B |
| Rubicon Research | 155.61B |
| Caplin Point Laboratories | 154.72B |
| Viyash Scientific | 112.11B |